http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-818120-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3ad99b9ce98f67919cc80cd097a27b3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
| filingDate | 1957-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1959-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-818120-A |
| titleOfInvention | An antihistaminic and cell protection serum |
| abstract | An antihistaminic and cell protection serum is prepared by injecting repeatedly a dilute aqueous solution of an inorganic salt of a histamine base, such as histamine dihydrochloride or double phosphate, or of an inorganic salt of a compound other than histamine having an imidazole nucleus, e.g. histidine hydrochloride, to a bay horse which was castrated at 3 years, previously vaccinated against glanders and phlebotomized, preferably over a period of four days at a daily rate of 0.1 mg. of histamine base per 10 kg. animal body weight, and then, at least four days after the last injection, drawing blood and extracting therefrom a serum which is tyndallized. The horse is fed on a nitrogen-rich diet preceding the bloodletting and during the period of the interventions. After the blood-letting the horse is given oxidants such as manganese dioxide, calcium glycerophosphate, ascorbic acid, iron sequioxide. |
| priorityDate | 1957-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.